This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Methylated Septin 9 is a DNA marker associated with colorectal cancer.
This is a blood test and no special patient preparation is required.
Expect results in 7-8 business days.
Please consult your physician to determine if this test is suitable for you.
Please be advised that our services are strictly self-pay and not eligible for submission as a claim to your health insurance provider, medical bill sharing company, Medicare/Medicaid or other third-party payor. QC 16983
